145 related articles for article (PubMed ID: 6254646)
21. The prognostic value of carcinoembryonic antigen in T1N1M0 and T2N1M0 non-small cell carcinoma of the lung.
Fukai R; Sakao Y; Sakuraba M; Oh S; Shiomi K; Sonobe S; Saitoh Y; Miyamoto H
Eur J Cardiothorac Surg; 2007 Sep; 32(3):440-4. PubMed ID: 17643308
[TBL] [Abstract][Full Text] [Related]
22. Carcinoembryonic antigen in patients with colorectal cancer: correlation between stage of disease and antigen level.
Bartal AH; Ayalon D; Cordova T; Avidan S; Robinson E
Isr J Med Sci; 1983 Sep; 19(9):801-5. PubMed ID: 6643017
[TBL] [Abstract][Full Text] [Related]
23. Serial plasma carcinoembryonic antigen measurement for monitoring patients with advanced lung cancer during chemotherapy.
Shinkai T; Saijo N; Tominaga K; Eguchi K; Shimizu E; Sasaki Y; Fujita J; Futami H; Ohkura H; Suemasu K
Cancer; 1986 Apr; 57(7):1318-23. PubMed ID: 3004689
[TBL] [Abstract][Full Text] [Related]
24. Increased CYFRA 21-1 and CEA levels are negative predictors of outcome in p-stage I NSCLC.
Muley T; Dienemann H; Ebert W
Anticancer Res; 2003; 23(5b):4085-93. PubMed ID: 14666606
[TBL] [Abstract][Full Text] [Related]
25. An evaluation of the clinical usefulness of CEA in colorectal cancer.
Torosian MH; Daly JM
Oncology (Williston Park); 1991 May; 5(5):41-4; discussion 44, 49-50, 52-3. PubMed ID: 1832005
[TBL] [Abstract][Full Text] [Related]
26. [Clinical significance of serum SCC Ag in patients with squamous cell carcinoma of the lung].
Zeng L
Zhonghua Wai Ke Za Zhi; 1993 Mar; 31(3):143-5. PubMed ID: 8223022
[TBL] [Abstract][Full Text] [Related]
27. Carcinoembryonic antigen as a predictive factor for postoperative tumor relapse in early-stage lung adenocarcinoma.
Sakao Y; Tomimitsu S; Takeda Y; Natsuaki M; Itoh T
Eur J Cardiothorac Surg; 2004 Apr; 25(4):520-2. PubMed ID: 15037265
[TBL] [Abstract][Full Text] [Related]
28. Decline in serum carcinoembryonic antigen and cytokeratin 19 fragment during chemotherapy predicts objective response and survival in patients with advanced nonsmall cell lung cancer.
Ardizzoni A; Cafferata MA; Tiseo M; Filiberti R; Marroni P; Grossi F; Paganuzzi M
Cancer; 2006 Dec; 107(12):2842-9. PubMed ID: 17103443
[TBL] [Abstract][Full Text] [Related]
29. [Diagnostic value of the assay of carbohydrate antigen 19-9 in patients with primary bronchial cancer].
Letanche G; Ogier I; Weynants P; Hartmann DJ; Ville G; Cordier JF; Brune J
Rev Pneumol Clin; 1985; 41(5):314-6. PubMed ID: 3006207
[TBL] [Abstract][Full Text] [Related]
30. [Serum beta 2-microglobulin and carcinoembryonic antigen in patients with bronchogenic carcinoma].
Cha RJ; Chen SJ; Xiao CZ; Liang XL; Zhou NK
Zhonghua Zhong Liu Za Zhi; 1986 Sep; 8(5):342-4. PubMed ID: 3552534
[TBL] [Abstract][Full Text] [Related]
31. Use of carcinoembryonic antigen in small cell lung cancer. Prognostic value and relation to the clinical course 1.
Laberge F; Fritsche HA; Umsawasdi T; Carr DT; Welch S; Murphy WK; Chiuten DF; Dhingra HM; Farha P; Spitzer G
Cancer; 1987 Jun; 59(12):2047-52. PubMed ID: 3032400
[TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of preoperative serum carcinoembryonic antigen level in lung adenocarcinoma but not squamous cell carcinoma.
Tomita M; Matsuzaki Y; Edagawa M; Shimizu T; Hara M; Onitsuka T
Ann Thorac Cardiovasc Surg; 2004 Apr; 10(2):76-80. PubMed ID: 15209547
[TBL] [Abstract][Full Text] [Related]
33. Serum carcinoembryonic antigen level in pN1 non-small cell lung cancer patients.
Tomita M; Matsuzaki Y; Shimizu T; Hara M; Ayabe T; Onitsuka T
Anticancer Res; 2005; 25(5):3601-5. PubMed ID: 16101187
[TBL] [Abstract][Full Text] [Related]
34. Carcinoembryonic antigen as differentiation marker for small cell lung cancer in vitro and its clinical relevance.
Bepler G; Ostholt M; Neumann K; Holle R; Jaques G; Havemann K; Kalbfleisch H
Anticancer Res; 1989; 9(6):1525-30. PubMed ID: 2483298
[TBL] [Abstract][Full Text] [Related]
35. Is there any clinical relevance of serial determinations of serum carcinoembryonic antigen in small cell lung cancer patients?
Krischke W; Niederle N; Schütte J; Pfeiffer R; Hirche H
Cancer; 1988 Oct; 62(7):1348-54. PubMed ID: 2843279
[TBL] [Abstract][Full Text] [Related]
36. Multiple sequential biomarkers in monitoring patients with carcinoma of the lung.
Aroney RS; Dermody WC; Aldenderfer P; Parsons P; McNitt K; Marangos PJ; Whitacre MY; Ruddon RW; Wiernik PH; Aisner J
Cancer Treat Rep; 1984 Jun; 68(6):859-66. PubMed ID: 6329508
[TBL] [Abstract][Full Text] [Related]
37. Carcinoembryonic antigen: a useful prognostic marker in small-cell lung cancer.
Sculier JP; Feld R; Evans WK; Shepherd FA; DeBoer G; Malkin DG; Malkin A
J Clin Oncol; 1985 Oct; 3(10):1349-54. PubMed ID: 2995598
[TBL] [Abstract][Full Text] [Related]
38. Indicative value of carcinoembryonic antigen (CEA) for liver recurrence following curative resection of stage II and III gastric cancer.
Ikeda Y; Mori M; Kajiyama K; Kamakura T; Maehara Y; Haraguchi Y; Sugimachi K
Hepatogastroenterology; 1996; 43(11):1281-7. PubMed ID: 8908563
[TBL] [Abstract][Full Text] [Related]
39. [The function of the level of serum carcinoembryonic antigen on early recurrence of non-small cell lung cancer].
Zhang ZF; Ma JQ; Sun N; Zhang L
Zhonghua Wai Ke Za Zhi; 2004 Jul; 42(13):817-9. PubMed ID: 15363304
[TBL] [Abstract][Full Text] [Related]
40. [Evaluation of plasma carcinoembryonic antigen (CEA) in patients with head and neck cancer: correlation with tissue CEA staining].
Kawasaki T; Nagamine T; Suzuki I; Shingaki S; Nakajima T; Suzuki M
Gan No Rinsho; 1986 Feb; 32(2):133-40. PubMed ID: 2421023
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]